An Innovative New Treatment Gives Hope to Women Who Have Difficulty Getting Pregnant

Food and Healthcare Press Releases Monday July 15, 2013 15:13
Bangkok--15 Jul--Spark Communications

MSD, one of the leading companies in the development of solutions in the IVF (In Vitro Fertilization) sector, has releaseda ground breaking new treatment for IVF patients which will make their lives a lot easier through a new fertility treatment.

This innovative new treatment gives hope to many women experiencing the emotional and physical stress of infertility issues, which is a sustained release follicle stimulating hormone (FSH) - the first of its kind. One significant benefit of using this new fertility treatment is the few number of treatments needed. Currently, women now undergoing IVF have to have a daily subcutaneous injection of FSH but this new solution means that they will only have to get an injection once a week.

This treatment is the first sustained follicle stimulant. Due to its ability to initiate and sustain multiple follicular growth for an entire week, a single subcutaneous injection of the recommended dose may replace the first seven injections of any the conventional daily follicle stimulating hormone (FSH) injections for controlled ovarian stimulation (COS).

Today, up to 15%of couples globally experience fertility problems. In Thailand, fertility rates are in decline from 4.9 children per woman(1975) to 1.6 children per woman(2013), which is considered to be below the generally accepted level of 2.1 children to maintain current population levels. Infertility is a disease that impairs the body's ability to perform the basic function of reproduction. Many causes including problems with the production of sperm or eggs, with the fallopian tubes or the uterus, endometriosis, frequent miscarriage, as well as hormonal and autoimmune disorders in both men and women.

There are some treatments available for infertility, which include surgery, hormone treatments, insemination and IVF. But in the past treatments were time consuming and painful. MSD's new treatment provides an effective, easy, and patient-focused fertility treatment.

Dr. Somjate Manipalviratn, Clinical Director Obstetrician and Gynecologist as well as a leading reproductive endocrinology and infertility specialist, says: "The advent of this new fertility treatment marks a new era of hope for our patients. Infertility is a relatively common problem worldwide and in Thailand, and this new innovative treatment makes it much easier for both patients and doctors. The solutionis a positive step towards reducing the burden of daily injections for women experiencing difficulty conceiving."

Latest Press Release

Venus Medtech Launches Global Advisory Board to Target for International Market

Venus Medtech (Hangzhou) Inc., a Chinese medical device company specializing in transcatheter valve replacement therapy, has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board. The Board...

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report " Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality...

PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group...

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular...

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

Related Topics